Literature DB >> 1541283

In vivo and in vitro studies of the purine-cytosine permease of Saccharomyces cerevisiae. Functional analysis of a mutant with an altered apparent transport constant of uptake.

D Brèthes1, M C Chirio, C Napias, M R Chevallier, J L Lavie, J Chevallier.   

Abstract

The FCY2 gene of the purine-cytosine permease (PCP) of Saccharomyces cerevisiae and the allele fcy2-21 have been cloned on the yeast multicopy plasmid pJDB207. The corresponding plasmids were introduced into a S. cerevisiae strain carrying a chromosomal deletion at the FCY2 locus. The resulting strains were designated pAB4 and pAB25 respectively. The pAB25 strain, which carries the fcy2-21 allele, contains four amino acid changes in the open reading frame of the PCP (Weber et al., 1989). The influence of these mutations was studied on cells by determination of the uptake constants of purine bases and cytosine [apparent Michaelis constant of transport (Ktapp) and Vmax] and on plasma-membrane preparations, by measurements of binding parameters at equilibrium [(Kd and maximum amount of binding sites/Bmax)]. For strain pAB4, the Ktapp and Vmax of uptake were almost similar for all solutes considered [1.8-2.6 microM and 8.5-10.2 nmol.min-1.(10(7) cells)-1]. The main effect of the mutations in strain pAB25 was based on a large increase in Ktapp for all ligands except adenine. Plasma membranes of each strain displayed one class of specific binding sites. Variations in Kd of 0.4-1 microM were observed for pAB4. These slight variations had no effect on the Ktapp of uptake measured for the corresponding solutes. In contrast, using pAB25 membranes, Kd increased dramatically; 2.6 microM, 40 microM and 96 microM for adenine, cytosine and hypoxanthine, respectively. These increments were correlated to variations in Ktapp of the uptake for cytosine and hypoxanthine. Therefore, we conclude that modification in the Ktapp of uptake in the strain carrying fcy2-21 allele is merely due to a modification of the binding ability of the permease for its ligands.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541283     DOI: 10.1111/j.1432-1033.1992.tb16684.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  New plasmid system to select for Saccharomyces cerevisiae purine-cytosine permease affinity mutants.

Authors:  R Wagner; M L Straub; J L Souciet; S Potier; J de Montigny
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

2.  Functional analyses of yeast purine-cytosine permease mutants.

Authors:  T Ferreira; D Brèthes; C Napias; J Chevallier
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

3.  Deletion of the uracil permease gene confers cross-resistance to 5-fluorouracil and azoles in Candida lusitaniae and highlights antagonistic interaction between fluorinated nucleotides and fluconazole.

Authors:  Frédéric Gabriel; Ayman Sabra; Sofiane El-Kirat-Chatel; Sophie Pujol; Valérie Fitton-Ouhabi; Daniel Brèthes; Karine Dementhon; Isabelle Accoceberry; Thierry Noël
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  Only one of the charged amino acids located in membrane-spanning regions is important for the function of the Saccharomyces cerevisiae uracil permease.

Authors:  B Pinson; J Chevallier; D Urban-Grimal
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

5.  The solute specificity profiles of nucleobase cation symporter 1 (NCS1) from Zea mays and Setaria viridis illustrate functional flexibility.

Authors:  Micah Rapp; Jessica Schein; Kevin A Hunt; Vamsi Nalam; George S Mourad; Neil P Schultes
Journal:  Protoplasma       Date:  2015-05-29       Impact factor: 3.356

6.  Replacement of Lys by Glu in a transmembrane segment strongly impairs the function of the uracil permease from Saccharomyces cerevisiae.

Authors:  D Urban-Grimal; B Pinson; J Chevallier; R Haguenauer-Tsapis
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

7.  Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.

Authors:  Thierry Noël; Fabienne François; Patrick Paumard; Christiane Chastin; Daniel Brèthes; Jean Villard
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

8.  Structure and molecular mechanism of a nucleobase-cation-symport-1 family transporter.

Authors:  Simone Weyand; Tatsuro Shimamura; Shunsuke Yajima; Shun'ichi Suzuki; Osman Mirza; Kuakarun Krusong; Elisabeth P Carpenter; Nicholas G Rutherford; Jonathan M Hadden; John O'Reilly; Pikyee Ma; Massoud Saidijam; Simon G Patching; Ryan J Hope; Halina T Norbertczak; Peter C J Roach; So Iwata; Peter J F Henderson; Alexander D Cameron
Journal:  Science       Date:  2008-10-16       Impact factor: 47.728

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.